RENAL AND ADRENAL RESPONSIVENESS TO ANGIOTENSIN-II - INFLUENCE OF BETA-ADRENERGIC-BLOCKADE

被引:19
作者
GORDON, MS
WILLIAMS, GH
HOLLENBERG, NK
机构
[1] BRIGHAM & WOMENS HOSP,75 FRANCIS ST,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT RADIOL,BOSTON,MA 02115
关键词
D O I
10.1080/07435809209035402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increase in aldosterone secretion that occurs in response to Angiotensin II (AII) is enhanced when normal humans are in external balance on a low salt diet. The responsible mechanism has not been identified. Angiotensin converting enzyme inhibition reduces blood levels of AII and aldosterone, but does not decrease PRA or AI and does not modify adrenal responsiveness to AII in the sodium-depleted state. This study was designed to assess the possibility that the enhanced adrenal response reflects plasma renin activity (PRA), plasma AI concentration, or catecholamines acting via a beta adrenergic receptor. Nine healthy males were studied when in balance on a high sodium intake (200 mmol Na/day), a low sodium diet (10 mmol Na) and after 4 days of beta adrenergic blockade with either nadolol or propranolol. The adequacy of beta adrenergic blockade was assessed with a postural stimulus and significant blockade was achieved, somewhat more with nadolol (40 mg/day) than with propranolol (Inderal LA 80 mg every 12 hrs). Beta blockade enhanced the renal vascular and pressor response to AII but did not modify the adrenal response to posture or to AII. This study confirms the role for AII levels in the modulation of renal vascular and pressor responses to AII and rules out a role for PRA, AI, or catecholamines acting via a beta adrenergic receptor in the modulation of adrenal responsiveness to AII.
引用
收藏
页码:115 / 131
页数:17
相关论文
共 24 条
[1]  
Bravo E L, 1977, Adv Nephrol Necker Hosp, V7, P105
[2]   PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J].
BUHLER, FR ;
BRUNNER, HR ;
BAER, L ;
VAUGHAN, ED ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) :1209-+
[3]   DOPAMINE SELECTIVELY INHIBITS ALDOSTERONE RESPONSES TO ANGIOTENSIN-II IN HUMANS [J].
CAREY, RM ;
DRAKE, CR .
HYPERTENSION, 1986, 8 (05) :399-406
[4]   COMPARISON BETWEEN SHORT-TERM RENAL HEMODYNAMIC-EFFECTS OF PROPRANOLOL AND NADOLOL IN ESSENTIAL-HYPERTENSION - A CROSSOVER STUDY [J].
DANESH, BJZ ;
BRUNTON, J ;
SUMNER, DJ .
CLINICAL SCIENCE, 1984, 67 (02) :243-248
[5]   PLASMA ANGIOTENSIN-II CONCENTRATION REGULATES VASCULAR BUT NOT ADRENAL RESPONSIVENESS TO RESTRICTION OF SODIUM-INTAKE IN NORMAL MAN [J].
DAWSONHUGHES, BF ;
MOORE, TJ ;
DLUHY, RG ;
HOLLENBERG, NK ;
WILLIAMS, GH .
CLINICAL SCIENCE, 1981, 61 (05) :527-534
[6]   ANGIOTENSIN RECEPTORS IN VASCULAR TISSUE [J].
DEVYNCK, MA ;
MEYER, P .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :758-767
[7]   REGULATION OF ANGIOTENSIN-II RECEPTORS IN RAT ADRENAL-CORTEX BY DIETARY ELECTROLYTES [J].
DOUGLAS, J ;
CATT, KJ .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (04) :834-843
[8]  
EMANUEL RL, 1973, J LAB CLIN MED, V81, P632
[9]   REGULATION BY ANGIOTENSIN-II OF ITS RECEPTORS IN RESISTANCE BLOOD-VESSELS [J].
GUNTHER, S ;
GIMBRONE, MA ;
ALEXANDER, RW .
NATURE, 1980, 287 (5779) :230-232
[10]  
HOLENBERG NK, 1979, BR J CLIN PHARM S2, V7, P219